AMRX - Amneal Pharmaceuticals Non-GAAP EPS of $0.14 beats by $0.05 revenue of $659M beats by $39.97M
2024-05-03 06:02:55 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Amneal Pharmaceuticals Q1 2024 Earnings Preview
- FDA approves Amneal's generic version of OTC Narcan
- Seeking Alpha’s Quant Rating on Amneal Pharmaceuticals